Ann L. Sharpley

4.2k total citations
57 papers, 3.1k citations indexed

About

Ann L. Sharpley is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Ann L. Sharpley has authored 57 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cognitive Neuroscience, 30 papers in Experimental and Cognitive Psychology and 20 papers in Psychiatry and Mental health. Recurrent topics in Ann L. Sharpley's work include Sleep and Wakefulness Research (30 papers), Sleep and related disorders (26 papers) and Circadian rhythm and melatonin (8 papers). Ann L. Sharpley is often cited by papers focused on Sleep and Wakefulness Research (30 papers), Sleep and related disorders (26 papers) and Circadian rhythm and melatonin (8 papers). Ann L. Sharpley collaborates with scholars based in United Kingdom, United States and Italy. Ann L. Sharpley's co-authors include Philip J. Cowen, Jenny McCleery, Daniel Cohen, R A Solomon, Derk‐Jan Dijk, Paul Gringras, Hugh Selsick, Colin A. Espie, David S. Baldwin and Peter A. Sargent and has published in prestigious journals such as The Lancet, Biological Psychiatry and Cochrane Database of Systematic Reviews.

In The Last Decade

Ann L. Sharpley

56 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann L. Sharpley United Kingdom 29 1.7k 1.5k 787 773 337 57 3.1k
Sue Wilson United Kingdom 25 1.2k 0.7× 1.1k 0.7× 420 0.5× 335 0.4× 448 1.3× 65 2.5k
Thomas Wessel United States 31 1.1k 0.6× 1.1k 0.7× 562 0.7× 505 0.7× 738 2.2× 48 3.4k
Usoa E. Busto Canada 25 948 0.6× 819 0.5× 192 0.2× 622 0.8× 483 1.4× 42 2.7k
Norbert Dahmen Germany 32 628 0.4× 829 0.5× 305 0.4× 625 0.8× 571 1.7× 107 3.2k
Goeran Hajak Germany 27 1.3k 0.8× 1.5k 1.0× 397 0.5× 242 0.3× 101 0.3× 45 3.0k
Eckart Rüther Germany 39 1.1k 0.7× 1.0k 0.7× 596 0.8× 1.5k 1.9× 590 1.8× 116 4.8k
Duane G. Spiker United States 28 809 0.5× 964 0.6× 282 0.4× 890 1.2× 258 0.8× 53 2.6k
Andrew W. Goddard United States 30 1.1k 0.7× 972 0.6× 306 0.4× 429 0.6× 838 2.5× 48 3.2k
Hans‐Peter Volz Germany 38 666 0.4× 1.2k 0.8× 214 0.3× 983 1.3× 512 1.5× 151 4.0k
Richard M. Mangano United States 21 786 0.5× 576 0.4× 280 0.4× 323 0.4× 813 2.4× 35 2.4k

Countries citing papers authored by Ann L. Sharpley

Since Specialization
Citations

This map shows the geographic impact of Ann L. Sharpley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann L. Sharpley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann L. Sharpley more than expected).

Fields of papers citing papers by Ann L. Sharpley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann L. Sharpley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann L. Sharpley. The network helps show where Ann L. Sharpley may publish in the future.

Co-authorship network of co-authors of Ann L. Sharpley

This figure shows the co-authorship network connecting the top 25 collaborators of Ann L. Sharpley. A scholar is included among the top collaborators of Ann L. Sharpley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann L. Sharpley. Ann L. Sharpley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godlewska, Beata R., Uzay Emir, Ann L. Sharpley, et al.. (2025). Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study. Molecular Psychiatry. 30(11). 5215–5226. 1 indexed citations
2.
Godlewska, Beata R., Uzay Emir, Ann L. Sharpley, et al.. (2024). Six-Week Supplementation with Creatine in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Magnetic Resonance Spectroscopy Feasibility Study at 3 Tesla. Nutrients. 16(19). 3308–3308. 1 indexed citations
3.
Sharpley, Ann L., Clare Williams, Beata R. Godlewska, et al.. (2020). A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania. Psychopharmacology. 237(12). 3773–3782. 46 indexed citations
4.
Godlewska, Beata R., Charles Masaki, Ann L. Sharpley, Philip J. Cowen, & Uzay Emir. (2017). Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla. Psychological Medicine. 48(10). 1731–1737. 38 indexed citations
5.
McCleery, Jenny, Daniel Cohen, & Ann L. Sharpley. (2016). Pharmacotherapies for sleep disturbances in dementia. Cochrane Database of Systematic Reviews. 11. CD009178–CD009178. 132 indexed citations
6.
Masaki, Charles, Ann L. Sharpley, Beata R. Godlewska, et al.. (2016). Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing. Psychopharmacology. 233(14). 2655–2661. 67 indexed citations
7.
Singh, Nisha, Ann L. Sharpley, Uzay Emir, et al.. (2015). Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans. Neuropsychopharmacology. 41(7). 1768–1778. 85 indexed citations
8.
Sharpley, Ann L., et al.. (2014). Folic acid supplementation for prevention of mood disorders in young people at familial risk: A randomised, double blind, placebo controlled trial. Journal of Affective Disorders. 167. 306–311. 18 indexed citations
9.
Wilson, SJ, DJ NUTT, Chris Alford, et al.. (2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of Psychopharmacology. 24(11). 1577–1601. 467 indexed citations
10.
Sharpley, Ann L., et al.. (2005). Olanzapine Increases Slow Wave Sleep and Sleep Continuity in SSRI-Resistant Depressed Patients. The Journal of Clinical Psychiatry. 66(4). 450–454. 52 indexed citations
11.
Sharpley, Ann L., et al.. (2003). Risperidone Augmentation Decreases Rapid Eye Movement Sleep and Decreases Wake in Treatment-Resistant Depressed Patients. The Journal of Clinical Psychiatry. 64(2). 192–196. 36 indexed citations
12.
Brunello, N., Roseanne Armitage, Irwin Feinberg, et al.. (2000). Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment. Neuropsychobiology. 42(3). 107–119. 53 indexed citations
13.
Sharpley, Ann L., et al.. (1998). Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram. Psychopharmacology. 139(3). 286–287. 21 indexed citations
14.
Sargent, Peter A., Ann L. Sharpley, Clare Williams, E. M. Goodall, & Philip J. Cowen. (1997). 5-HT 2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology. 133(3). 309–312. 125 indexed citations
15.
Sharpley, Ann L., et al.. (1996). Effect of nefazodone and lithium on sleep architecture in healthy men. Journal of Psychopharmacology. 10(1). 26–29. 8 indexed citations
16.
Young, Allan H., et al.. (1994). Effects of hydrocortisone on brain 5-HT function and sleep. Journal of Affective Disorders. 32(2). 139–146. 33 indexed citations
17.
Sharpley, Ann L., Anne E.S. Walsh, & Philip J. Cowen. (1992). Nefazodone—A novel antidepressant— May increase REM sleep. Biological Psychiatry. 31(10). 1070–1073. 56 indexed citations
18.
Sharpley, Ann L., R A Solomon, & Philip J. Cowen. (1990). Sleep Stability with Home Sleep Recording and Automatic Sleep Stage Analysis. SLEEP. 13(6). 538–540. 17 indexed citations
19.
Elphick, M.C., et al.. (1989). Effects of carbamazepine on sleep in healthy volunteers. Biological Psychiatry. 26(3). 324–328. 49 indexed citations
20.
Sharpley, Ann L., R A Solomon, & Philip J. Cowen. (1988). Evaluation of First Night Effect using Ambulatory Monitoring and Automatic Sleep Stage Analysis. SLEEP. 11(3). 273–276. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sue Wilson Breakdown of academic impact, for papers by Thomas Wessel Breakdown of academic impact, for papers by Usoa E. Busto Breakdown of academic impact, for papers by Norbert Dahmen Breakdown of academic impact, for papers by Goeran Hajak Breakdown of academic impact, for papers by Eckart Rüther Breakdown of academic impact, for papers by Duane G. Spiker Breakdown of academic impact, for papers by Andrew W. Goddard Breakdown of academic impact, for papers by Hans‐Peter Volz Breakdown of academic impact, for papers by Richard M. Mangano
Rankless by CCL
2026